220 related articles for article (PubMed ID: 16951254)
21. Impairing MLL-fusion gene-mediated transformation by dissecting critical interactions with the lens epithelium-derived growth factor (LEDGF/p75).
Méreau H; De Rijck J; Cermáková K; Kutz A; Juge S; Demeulemeester J; Gijsbers R; Christ F; Debyser Z; Schwaller J
Leukemia; 2013 Jun; 27(6):1245-53. PubMed ID: 23318960
[TBL] [Abstract][Full Text] [Related]
22. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
Muntean AG; Hess JL
Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728
[TBL] [Abstract][Full Text] [Related]
23. A pharmacologic inhibitor of the protease Taspase1 effectively inhibits breast and brain tumor growth.
Chen DY; Lee Y; Van Tine BA; Searleman AC; Westergard TD; Liu H; Tu HC; Takeda S; Dong Y; Piwnica-Worms DR; Oh KJ; Korsmeyer SJ; Hermone A; Gussio R; Shoemaker RH; Cheng EH; Hsieh JJ
Cancer Res; 2012 Feb; 72(3):736-46. PubMed ID: 22166309
[TBL] [Abstract][Full Text] [Related]
24. Involvement of Gpr125 in the myeloid sarcoma formation induced by cooperating MLL/AF10(OM-LZ) and oncogenic KRAS in a mouse bone marrow transplantation model.
Fu JF; Yen TH; Chen Y; Huang YJ; Hsu CL; Liang DC; Shih LY
Int J Cancer; 2013 Oct; 133(8):1792-802. PubMed ID: 23564351
[TBL] [Abstract][Full Text] [Related]
25. Mixed lineage leukemia: roles in gene expression, hormone signaling and mRNA processing.
Ansari KI; Mandal SS
FEBS J; 2010 Apr; 277(8):1790-804. PubMed ID: 20236313
[TBL] [Abstract][Full Text] [Related]
26. Design, syntheses, and evaluation of Taspase1 inhibitors.
Lee JT; Chen DY; Yang Z; Ramos AD; Hsieh JJ; Bogyo M
Bioorg Med Chem Lett; 2009 Sep; 19(17):5086-90. PubMed ID: 19631530
[TBL] [Abstract][Full Text] [Related]
27. Species selectivity of mixed-lineage leukemia/trithorax and HCF proteolytic maturation pathways.
Capotosti F; Hsieh JJ; Herr W
Mol Cell Biol; 2007 Oct; 27(20):7063-72. PubMed ID: 17698583
[TBL] [Abstract][Full Text] [Related]
28. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
Luo RT; Lavau C; Du C; Simone F; Polak PE; Kawamata S; Thirman MJ
Mol Cell Biol; 2001 Aug; 21(16):5678-87. PubMed ID: 11463848
[TBL] [Abstract][Full Text] [Related]
29. Bioassays to monitor Taspase1 function for the identification of pharmacogenetic inhibitors.
Knauer SK; Fetz V; Rabenstein J; Friedl S; Hofmann B; Sabiani S; Schröder E; Kunst L; Proschak E; Thines E; Kindler T; Schneider G; Marschalek R; Stauber RH; Bier C
PLoS One; 2011; 6(5):e18253. PubMed ID: 21647428
[TBL] [Abstract][Full Text] [Related]
30. Structural Characterization of the Loop at the Alpha-Subunit C-Terminus of the Mixed Lineage Leukemia Protein Activating Protease Taspase1.
van den Boom J; Trusch F; Hoppstock L; Beuck C; Bayer P
PLoS One; 2016; 11(3):e0151431. PubMed ID: 26974973
[TBL] [Abstract][Full Text] [Related]
31. MLL associates specifically with a subset of transcriptionally active target genes.
Milne TA; Dou Y; Martin ME; Brock HW; Roeder RG; Hess JL
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14765-70. PubMed ID: 16199523
[TBL] [Abstract][Full Text] [Related]
32. Deubiquitinating enzyme inhibitor alleviates cyclin A1-mediated proteasome inhibitor tolerance in mixed-lineage leukemia.
Ge M; Xu Q; Kang T; Li D; Wang R; Chen Z; Xie S; Wang W; Liu H
Cancer Sci; 2021 Jun; 112(6):2287-2298. PubMed ID: 33738896
[TBL] [Abstract][Full Text] [Related]
33. Taspase1: a 'misunderstood' protease with translational cancer relevance.
Wünsch D; Hahlbrock A; Jung S; Schirmeister T; van den Boom J; Schilling O; Knauer SK; Stauber RH
Oncogene; 2016 Jun; 35(26):3351-64. PubMed ID: 26657154
[TBL] [Abstract][Full Text] [Related]
34. Taspase1-dependent TFIIA cleavage coordinates head morphogenesis by limiting Cdkn2a locus transcription.
Takeda S; Sasagawa S; Oyama T; Searleman AC; Westergard TD; Cheng EH; Hsieh JJ
J Clin Invest; 2015 Mar; 125(3):1203-14. PubMed ID: 25664857
[TBL] [Abstract][Full Text] [Related]
35. Cell-based analysis of structure-function activity of threonine aspartase 1.
Bier C; Knauer SK; Klapthor A; Schweitzer A; Rekik A; Krämer OH; Marschalek R; Stauber RH
J Biol Chem; 2011 Jan; 286(4):3007-17. PubMed ID: 21084304
[TBL] [Abstract][Full Text] [Related]
36. mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues.
Robinson BW; Germano G; Song Y; Abrams J; Scott M; Guariento I; Tiso N; Argenton F; Basso G; Rhodes J; Kanki JP; Look AT; Balice-Gordon RJ; Felix CA
Br J Haematol; 2011 Feb; 152(3):307-21. PubMed ID: 21155757
[TBL] [Abstract][Full Text] [Related]
37. Structural insights into the function of the catalytically active human Taspase1.
Nagaratnam N; Delker SL; Jernigan R; Edwards TE; Snider J; Thifault D; Williams D; Nannenga BL; Stofega M; Sambucetti L; Hsieh JJ; Flint AJ; Fromme P; Martin-Garcia JM
Structure; 2021 Aug; 29(8):873-885.e5. PubMed ID: 33784495
[TBL] [Abstract][Full Text] [Related]
38. Taspase1 Facilitates Topoisomerase IIβ-Mediated DNA Double-Strand Breaks Driving Estrogen-Induced Transcription.
Oelschläger L; Stahl P; Kaschani F; Stauber RH; Knauer SK; Hensel A
Cells; 2023 Jan; 12(3):. PubMed ID: 36766705
[TBL] [Abstract][Full Text] [Related]
39. Closantel is an allosteric inhibitor of human Taspase1.
Luciano V; Proschak E; Langer JD; Knapp S; Heering J; Marschalek R
iScience; 2021 Dec; 24(12):103524. PubMed ID: 34934933
[TBL] [Abstract][Full Text] [Related]
40. Mutations in Mll2, an H3K4 methyltransferase, result in insulin resistance and impaired glucose tolerance in mice.
Goldsworthy M; Absalom NL; Schröter D; Matthews HC; Bogani D; Moir L; Long A; Church C; Hugill A; Anstee QM; Goldin R; Thursz M; Hollfelder F; Cox RD
PLoS One; 2013; 8(6):e61870. PubMed ID: 23826075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
